EcoR1 Capital, LLC and Oleg Nodelman filed a Form 4 with the SEC on November 18, 2026, disclosing three open-market purchases of AnaptysBio, Inc. common stock totaling 374,580 shares acquired between November 16 and November 18, 2026.

Key Highlights

  • Three purchases in three days: EcoR1 Capital bought 84,120 shares on November 16, 152,367 shares on November 17, and 138,093 shares on November 18, 2026.
  • Prices per share: The reported average prices were $45.6624 on November 16, $45.6553 on November 17, and $46.5419 on November 18, 2026.
  • Total beneficial ownership after transactions: Following the November 18 purchase, the reporting persons indirectly beneficially owned 8,254,674 shares of AnaptysBio common stock.
  • Qualified Fund holdings: After the final transaction, EcoR1 Capital Fund Qualified L.P. held 7,642,937 shares of AnaptysBio common stock, according to the filing.
  • Reporting persons: The filing was made jointly by EcoR1 Capital, LLC and Oleg Nodelman, who is described as manager and controlling owner of EcoR1 and a director of AnaptysBio.
  • Dual roles: Both EcoR1 Capital and Nodelman are identified in the filing as director and 10% owner of the issuer.

EcoR1 Capital and Nodelman Disclose Accumulation of AnaptysBio Shares

According to the Form 4 filed on NASDAQ:ANAB, EcoR1 Capital, LLC and Oleg Nodelman reported three separate open-market purchases of AnaptysBio, Inc. common stock over consecutive trading days. All transactions carried transaction code "P," indicating open-market purchases. The shares are held indirectly through private funds for which EcoR1 serves as investment adviser and general partner.

The filing notes that EcoR1 Capital Fund Qualified L.P. ("Qualified Fund") participated in the November 17 and November 18 transactions but not the November 16 purchase. Specifically, Qualified Fund purchased 113,048 of the 152,367 shares acquired on November 17 and 127,917 of the 138,093 shares acquired on November 18. The filing states that after the November 17 transaction Qualified Fund held 7,515,020 shares, rising to 7,642,937 shares after the November 18 transaction.

The filing states that EcoR1 "may be deemed to indirectly beneficially own" the securities as investment adviser to the funds, and that Nodelman "may be deemed to indirectly beneficially own them as the control person of EcoR1." The filers state they disclaim beneficial ownership "except to the extent of their pecuniary interests therein." The filing further states that the filers are reporting jointly "but not as a group" and that each "expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934."

What Was Disclosed

EcoR1 Capital, LLC and Oleg Nodelman disclosed three open-market purchases of AnaptysBio common stock between November 16 and November 18, 2026, totaling 374,580 shares at prices ranging from $45.6553 to $46.5419, bringing their total indirect beneficial ownership to 8,254,674 shares.